OUP Management Company’s Precision BioSciences DTIL Stock Holding History

OUP Management Company’s Portfolio DTIL Stock Details DTIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$384K	Hold	37,464	–	–	0.86%	9
2023 Q2	$591K	Hold	37,464	–	–	1.01%	10
2023 Q1	$847K	Hold	37,464	–	–	1.69%	11
2022 Q4	$1.34M	Hold	37,464	–	–	2.18%	10
2022 Q3	$1.46M	Hold	37,464	–	–	2.28%	8
2022 Q2	$1.8M	Hold	37,464	–	–	2.47%	9
2022 Q1	$3.46M	Hold	37,464	–	–	2.64%	9
2021 Q4	$8.32M	Buy	+37,464	New	+$10.5M	3.75%	8

Other funds holding DTIL

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

OUP Management Company's DTIL Position: Q3 2023 in Review

OUP Management Company held its Precision BioSciences (DTIL) position steady in Q3 2023 at 37,464 shares worth $384K. The position accounts for 0.86% of the portfolio, ranked #9.

OUP Management Company first reported a position in DTIL in Q4 2021 and has held it in 8 quarters since. The position peaked at $8.32M in Q4 2021. 76 funds tracked by Wall St. Rank hold DTIL as of Q3 2023.

OUP Management Company held 37,464 shares of Precision BioSciences worth $384K as of Q3 2023.
OUP Management Company left its Precision BioSciences share count unchanged in Q3 2023.
Precision BioSciences made up 0.86% of OUP Management Company's portfolio in Q3 2023, its #9 holding.
OUP Management Company first reported a position in Precision BioSciences in Q4 2021 and has held it in 8 quarters since.
OUP Management Company's Precision BioSciences position peaked at $8.32M in Q4 2021.
76 funds tracked by Wall St. Rank held Precision BioSciences as of Q3 2023.

Based on OUP Management Company's 13F filing for Q3 2023, filed 9 Nov 2023.